OTEZLA XR FDA approval date

The FDA approved OTEZLA XR on 29 Aug 2025.

FDA approval date
29 Aug 2025

Drug identity has not yet been verified against registry records

Also recorded as APREMILAST

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-08-29DayOTEZLA XRFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA210745", "applicant_as_listed_by_fda": "AMGEN INC", "brand_names": ["OTEZLA", "OTEZLA XR"], "active_ingredients": ["APREMILAST"], "submission_type": "ORIG", "submission_number": "2", "submission_status": "AP", "submission_status_date": "20250829", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026